This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Freedman, J. E. Search for Related Content PubMed PubMed Citation Articles by Freedman, J. E. Related Collections Arterial thrombosis Aggregation Platelet function inhibitors Acute coronary syndromes Platelets Related Article

(Circulation. 2007;115:2468-2470.)
© 2007 American Heart Association, Inc.

Editorial

Heritability, Platelet Function, and Aspirin

A Link Established but Cause Unknown

Jane E. Freedman, MD

From the Division of Cardiology, Boston University School of Medicine, Boston, Mass.

Correspondence to Jane E. Freedman, MD, Boston University School of Medicine, 715 Albany St, W507, Boston, MA 02118. E-mail freedmaj@bu.edu

Key Words: Editorials • aspirin • platelets • thrombosis • thromboxane

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Platelets play a critical role in the pathophysiology of atherothrombotic disease. A pivotal event contributing to the understanding of platelet-dependent clot formation was the development of the platelet aggregometer in 1962.¹ An aggregometer specifically measures the ability of platelets to adhere via glycoprotein IIb/IIIa (integrin _IIbß3), and thousands of articles using this technique have been published, characterizing platelet function; however, the usefulness of these measurements remains unclear. Whereas the aggregometer and related techniques that measure platelet aggregation or glycoprotein expression have led to large amounts of data characterizing platelet function in various settings, the clinical importance of measurable differences in platelet function is still debated.² The use of platelet function testing is established in rarer platelet abnormalities, such as the autosomal recessive bleeding disorder Glanzmann thrombasthenia,³ but no clear consensus has been reached on its usefulness for highly prevalent diseases caused by platelet-dependent thrombosis, such as myocardial infarction. A major factor for this discrepancy is that many of the platelet function defects that lead to bleeding are known to be caused by a single defect, whereas thrombosis in the setting of cardiovascular disease is presumed to be multifactorial.

Article p 2490

The evolution of platelet function studies in various clinical settings has led to the realization that wide interindividual variability exists in the platelet activation response.^4,5 What accounts for this variability? Only a few studies have systematically examined this question. Platelet function has been established as markedly dependent on the type of agonist used, the agonist concentration, and the concomitant . . . [Full Text of this Article]

Related Article:

Issue Highlights
Circulation 2007 115: 2459. [Extract] [Full Text]

This article has been cited by other articles:

				D. J. Fitzgerald and A. Maree Aspirin and Clopidogrel Resistance Hematology, January 1, 2007; 2007(1): 114 - 120. [Abstract] [Full Text] [PDF]